Kiernan T. DeAngelis
Technik-/Wissenschafts-/F&E-Leiter bei Humacyte Global, Inc.
Profil
Kiernan T.
DeAngelis is currently the Chief Medical Officer at Humacyte Global, Inc. Prior to this, he served as the Global Medical Director at AstraZeneca PLC from 2017 to 2019 and as the Senior Medical Director at United Therapeutics Corp.
from 2013 to 2017.
He also previously held the position of Chief Medical Officer at Humacyte, Inc. from 2020 to 2021.
Dr. DeAngelis completed his undergraduate degree at North Carolina State University and obtained his doctorate from Brody School of Medicine.
Aktive Positionen von Kiernan T. DeAngelis
| Unternehmen | Position | Beginn |
|---|---|---|
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 |
Ehemalige bekannte Positionen von Kiernan T. DeAngelis
| Unternehmen | Position | Ende |
|---|---|---|
| HUMACYTE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2021 |
| ASTRAZENECA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2019 |
| UNITED THERAPEUTICS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2017 |
Ausbildung von Kiernan T. DeAngelis
| Brody School of Medicine | Doctorate Degree |
| North Carolina State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| HUMACYTE, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
